Cabot (NYSE:CBT) Updates FY 2026 Earnings Guidance

Cabot (NYSE:CBT) issued an update on its FY 2026 earnings guidance on Monday morning. The company provided EPS guidance of 6.150-6.450 for the period, compared to the consensus estimate of 6.320. The company issued revenue guidance of -.

Cabot Price Performance

Shares of NYSE:CBT traded up $1.98 on Monday, reaching $90.00. 550,708 shares of the company were exchanged, compared to its average volume of 473,501. The company has a 50-day moving average of $87.89 and a 200-day moving average of $79.43. The company has a current ratio of 1.45, a quick ratio of 0.96 and a debt-to-equity ratio of 0.51. The firm has a market cap of $4.65 billion, a price-to-earnings ratio of 17.01, a price-to-earnings-growth ratio of 11.46 and a beta of 0.83. Cabot has a 1-year low of $58.33 and a 1-year high of $94.53.

Cabot (NYSE:CBT) last announced its quarterly earnings data on Monday, August 3rd. The specialty chemicals company reported $1.67 EPS for the quarter, beating the consensus estimate of $1.65 by $0.02. Cabot had a net margin of 7.97% and a return on equity of 21.33%. The firm had revenue of $982.00 million during the quarter, compared to analysts’ expectations of $943.16 million. Cabot has set its FY 2026 guidance at 6.150-6.450 EPS. Equities analysts forecast that Cabot will post 6.35 earnings per share for the current fiscal year.

Cabot Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, September 11th. Investors of record on Friday, August 28th will be paid a $0.4725 dividend. The ex-dividend date of this dividend is Friday, August 28th. This represents a $1.89 dividend on an annualized basis and a yield of 2.1%. Cabot’s dividend payout ratio is presently 35.73%.

Wall Street Analyst Weigh In

A number of research firms have issued reports on CBT. Mizuho upped their target price on shares of Cabot from $80.00 to $90.00 and gave the company a “neutral” rating in a report on Thursday, June 25th. Weiss Ratings reissued a “hold (c)” rating on shares of Cabot in a research report on Tuesday, May 26th. Wall Street Zen downgraded shares of Cabot from a “buy” rating to a “hold” rating in a research note on Saturday. UBS Group upped their price objective on shares of Cabot from $81.00 to $86.00 and gave the company a “neutral” rating in a research note on Friday, May 8th. Finally, Truist Financial started coverage on shares of Cabot in a research report on Monday, June 8th. They set a “buy” rating and a $98.00 target price on the stock. Two research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and a consensus target price of $85.80.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently modified their holdings of the stock. Geneos Wealth Management Inc. lifted its holdings in shares of Cabot by 409.0% during the 1st quarter. Geneos Wealth Management Inc. now owns 453 shares of the specialty chemicals company’s stock worth $38,000 after acquiring an additional 364 shares during the period. Global Retirement Partners LLC grew its holdings in Cabot by 1,606.9% in the fourth quarter. Global Retirement Partners LLC now owns 495 shares of the specialty chemicals company’s stock valued at $33,000 after purchasing an additional 466 shares during the period. Danske Bank A S acquired a new position in Cabot during the third quarter worth approximately $38,000. Caitong International Asset Management Co. Ltd increased its position in Cabot by 709.1% during the third quarter. Caitong International Asset Management Co. Ltd now owns 534 shares of the specialty chemicals company’s stock worth $41,000 after purchasing an additional 468 shares during the last quarter. Finally, Advisory Services Network LLC purchased a new position in Cabot during the third quarter worth approximately $57,000. Institutional investors and hedge funds own 93.18% of the company’s stock.

About Cabot

Cabot Corporation is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. Founded in 1882 by Godfrey Lowell Cabot, the company has grown into a diversified manufacturer with operations across North America, Europe, Asia and Latin America. Cabot serves a wide range of end markets, including automotive, industrial, energy, and consumer products, supplying essential ingredients that enhance performance, durability and functionality.

The company operates two primary segments: Reinforcement Materials and Performance Materials.